Numerous studies of the concentration of IL-6 in the blood and ascites of patients with ovarian cancer confirm increased levels of this protein in neoplastic disease and the correlation of IL-6 secretion with the advanced stage of the disease. Here, IL6 is linked to ovarian carcinoma.